当前位置:首页 > 股票大全 > 贝达药业 300558 财务分析

贝达药业财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

贝达药业(300558)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入735,775,468.82,456,196,486.622,043,551,452.91,313,877,968.81
营业总成本641,561,760.142,213,916,621.771,805,104,808.621,230,251,651.55
营业利润108,359,629.25270,069,503.79237,023,065.2186,438,503.18
利润总额107,227,308.89322,074,564.19291,784,917.03142,206,982.49
净利润93,790,802.53333,615,704.19294,122,417.51141,577,333.72
其他综合收益147,493,168.2260,755,488.958,433,019.4833,925,385.56
综合收益总额241,283,970.75394,371,193.14302,555,436.99175,502,719.28
贝达药业(300558)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,291,522,377.581,525,880,626.511,750,130,691.981,723,635,418
非流动资产合计8,034,937,681.37,621,027,769.027,077,134,362.756,880,392,384.13
资产总计9,326,460,058.889,146,908,395.538,827,265,054.738,604,027,802.13
流动负债合计1,420,328,462.731,803,156,867.031,578,792,449.281,352,461,519.3
非流动负债合计2,293,291,663.581,992,277,869.71,906,380,183.192,095,234,360.71
负债合计3,713,620,126.313,795,434,736.733,485,172,632.473,447,695,880.01
归属于母公司股东权益合计5,522,175,127.325,251,077,081.95,244,905,793.255,055,232,255.6
股东权益合计5,612,839,932.575,351,473,658.85,342,092,422.265,156,331,922.12
负债和股东权益合计9,326,460,058.889,146,908,395.538,827,265,054.738,604,027,802.13
贝达药业(300558)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计868,051,394.752,971,883,647.832,139,574,472.811,367,920,231.74
经营活动现金流出小计620,815,791.632,057,655,670.331,579,586,373.271,007,559,417.49
经营活动产生的现金流量净额247,235,603.12914,227,977.5559,988,099.54360,360,814.25
投资活动现金流入小计-22,213,036.8822,476,71522,620,698.46
投资活动现金流出小计491,145,434.911,527,665,941.921,260,612,771.96911,472,780.64
投资活动产生的现金流量净额-491,145,434.91-1,505,452,905.04-1,238,136,056.96-888,852,082.18
筹资活动现金流入小计308,600,0001,950,788,152.191,800,788,152.191,556,995,335.39
筹资活动现金流出小计261,025,439.531,342,594,801.631,165,539,006.611,103,376,969.75
筹资活动产生的现金流量净额47,574,560.47608,193,350.56635,249,145.58453,618,365.64
汇率变动对现金及现金等价物的影响-1,641,143.493,743,631.85,924,487.526,697,144.46
现金及现金等价物净增加额-197,976,414.8120,712,054.82-36,974,324.32-68,175,757.83
期末现金及现金等价物余额554,020,499.69751,996,914.5694,310,535.36663,109,101.85
贝达药业300558相关数据
今日股市大盘指数